What are the implications of anticoagulant therapy for patients with obesity-related complications, and how does weight affect treatment efficacy and safety?
Gaurav ChauhanContributor
What are the implications of anticoagulant therapy for patients with obesity-related complications?
Share
Anticoagulant therapy in obese patients often requires dose adjustments due to altered drug pharmacokinetics, potentially leading to reduced efficacy or increased risk of bleeding.